Rabies claims 100 lives annually in Vietnam: UN

Generics |  Analysis | By BioSpectrum Bureau  | 2 Comment | 30 Sep, 2013

Singapore: Vietnam has seen a substantial increase in the number of rabies fatalities from 34 deaths in 2003 to 131 deat...Read more

Now Ranbaxy's Mohali unit under FDA scanner

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jun, 2013

Singapore: Merely a month after Indian drug major, Ranbaxy, pleaded guilty of having misled the USFDA investigations, se...Read more

Mundipharma, Shionogi tie up for pain treatment in Japan

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 22 Nov, 2013

Singapore: Mundipharma has entered a license agreement with Japan-based Shionogi for the exclusive rights to develop, ma...Read more

GSK files for approval on melanoma drug combo

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2013

Singapore: Britian's leading drug maker, GlaxoSmithKline has filed for US Food and Drug Administration (US FDA) approval...Read more

TB prevention faces gap of $1.6bn: WHO estimates

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

Singapore: WHO and Global Fund to Fight AIDS, TB and Malaria have stressed on strains of tuberculosis with resistance to...Read more

Avanir Pharma settles patent litigation with Wockhardt

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Sep, 2013

Singapore: US based Avanir Pharmaceuticals has entered into a settlement agreement with India's Wockhardt to resolve pen...Read more

TWi Pharma gets FDA nod for ADHD drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 15 May, 2013

Singapore: Taiwan-based TWi Pharmaceuticals has received tentative approval for its Abbreviated New Drug Application (AN...Read more

Sandoz launches trial with Amgen biosimilar

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

Singapore: The generics unit of Novartis, Sandoz, has launched a late-stage trial with its biosimilar version of Amgen's...Read more

US company leverages on generics

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore: US based Par Pharmaceutical has entered into agreements with Watson Pharmaceuticals and Actavis Group to purc...Read more

NATCO wins compulsory license for anti-cancer drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 16 Mar, 2012

In a landmark decision, Hyderabad-based NATCO Pharma has been granted compulsory license for Sorafenib Tosylate sold und...Read more

Mylan gets FDA nod for Thiamine Hydrochloride Injection

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2012

Singapore: Mylan Institutional business has received final approval from the US Food and Drug Administration (FDA) for ...Read more

Big pharma to drive R&D innovation with $4.4 bn

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2013

Singapore: The European Commission (EC) and other leading pharma giants have come together to invest $4.4 billion into p...Read more

Multiple organzations join hands to curb fake drug business

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore: US Pharmacopeial Convention (USP) is gearing up its efforts to combat fake medicine circulating in the market...Read more

Arvind sets up $42.37 mn plant top tap US market

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

Singapore: Indian pharmaceutical firm, Arvind Remedies has been gearing up to take the US market by storm. The company h...Read more

Lilly strengthens its foothold in China

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

Singapore, June 15, 2012:  In support of its commitment to maximize growth opportunities in China, Eli Lilly has plans ...Read more

Cipla gets drug pricing breather from Delhi Court

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

Singapore: India's Delhi High Court has extended the operation of its earlier order asking the central government not t...Read more

Industry body expresses concern over Nexavar decision

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 16 Mar, 2012

The Association of Biotechnology Led Enterprises (ABLE), a national forum that represents the $4 billion biotechnology i...Read more

US FDA approves Suprax 400 mg by Lupin

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 06 Jun, 2012

Mumbai: Lupin Pharmaceuticals, a subsidiary of India-based Lupin, has received approval for Suprax (Cefixime) Capsules 4...Read more